Top Cigna Corporation Competitors and Alternatives | Bullfincher

Cigna Corporation +

+

Company

Cigna Corporation

Ticker

CI

Headquarter

Bloomfield ,CT

US

CEO

Mr. David Michael Cordani

Industry

Medical - Healthcare Plans

Stock Price

Stock Price

Market Cap

$91.01 B

Employees

Years

2022
2023
2024

Employees

71.30 K
72.50 K
73.50 K

Y/Y

3.26%

1.68%

1.38%

Revenue Per Employee

Years

2022
2023
2024

Revenue Per Employee

$2.52 M
$2.69 M
$3.32 M

Y/Y

6.78%

6.62%

23.5%

Net Income Per Employee

Years

2022
2023
2024

Net Income Per Employee

$94.03 K
$71.23 K
$46.72 K

Y/Y

29.04%

24.25%

34.41%

Income Statement

Revenue

Years

2022
2023
2024

Revenue

$180.03 B
$195.19 B
$244.38 B

Y/Y

3.31%

8.42%

25.21%

Revenue by Products / Services

Revenue by Geography

Research and Development

Years

2022
2023
2024

Research and Development

-
-
-

Y/Y

0%

0%

0%

Operating Income

Years

2022
2023
2024

Operating Income

$8.45 B
$8.54 B
$5.27 B

Y/Y

6.41%

1.02%

38.27%

Tax Rate (%)

Years

2022
2023
2024

Tax Rate (%)

19.00%
3.00%
28.00%

Y/Y

4.71%

86.69%

1005.47%

Net Income

Years

2022
2023
2024

Net Income

$6.70 B
$5.16 B
$3.43 B

Y/Y

24.84%

22.97%

33.5%

Assets & Liabilities | Cash Flow

Total Assets

Years

2022
2023
2024

Total Assets

$143.93 B
$152.76 B
$155.88 B

Y/Y

7.07%

6.13%

2.04%

Total Liabilities

Years

2022
2023
2024

Total Liabilities

$98.98 B
$106.41 B
$114.64 B

Y/Y

8.1%

7.51%

7.73%

Capital Expenditures (Capex)

Years

2022
2023
2024

Capital Expenditures (Capex)

-$1.30 B
-$1.57 B
-$1.41 B

Y/Y

12.22%

21.47%

10.62%

Profitability

Operating Income Margin (%)

Years

2022
2023
2024

Operating Income Margin (%)

4.69%
4.37%
2.16%

Y/Y

2.85%

6.82%

50.57%

Net Income Margin (%)

Years

2022
2023
2024

Net Income Margin (%)

3.72%
2.65%
1.41%

Y/Y

20.78%

28.76%

46.79%

EBITDA

2021	10413000000.00
2022	12908000000.00
2023	9574000000.00
2024	9479000000.00

Years

2022
2023
2024

EBITDA

$12.91 B
$9.57 B
$9.48 B

Y/Y

23.96%

25.83%

0.99%

Free Cash Flow (FCF)

2021	6037000000.00
2022	7361000000.00
2023	10240000000.00
2024	8957000000.00

Years

2022
2023
2024

Free Cash Flow (FCF)

$7.36 B
$10.24 B
$8.96 B

Y/Y

21.93%

39.11%

12.53%

Ratios

Return on Equity (ROE)

Years

2022
2023
2024

Return on Equity (ROE)

14.94%
11.17%
8.37%

Y/Y

31.05%

25.23%

25.07%

Return on Assets (ROA)

Years

2022
2023
2024

Return on Assets (ROA)

4.66%
3.38%
2.20%

Y/Y

34.29%

27.47%

34.91%

Debt to Equity

Years

2022
2023
2024

Debt to Equity

69.29%
66.91%
77.92%

Y/Y

3.05%

3.43%

16.45%

Valuation

Enterprise Value

Years

2022
2023
2024

Enterprise value

$128.90 B
$111.11 B
$101.82 B

Y/Y

21.38%

13.8%

8.36%

Enterprise value to Revenue

Years

2022
2023
2024

Enterprise value to Revenue

0.72
0.57
0.42

Y/Y

17.49%

20.49%

26.82%

Enterprise value to EBITDA

Years

2022
2023
2024

Enterprise value to EBITDA

9.99
11.61
10.74

Y/Y

2.08%

16.22%

7.44%